Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.
about
Therapeutic cancer vaccines: past, present, and futureThe evolution of poxvirus vaccinesCharacterization and Structure of the Vaccinia Virus NF-κB Antagonist A46Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein familyNonreplicating vectors in HIV vaccines.HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication studyHost factor SAMHD1 restricts DNA viruses in non-dividing myeloid cellsCD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.Functional paralysis of GM-CSF-derived bone marrow cells productively infected with ectromelia virus.Virotherapy, gene transfer and immunostimulatory monoclonal antibodies.Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responsesSafety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.Enhancing poxvirus vectors vaccine immunogenicity.Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infectionIncreased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys.Genetic cancer vaccines: current status and perspectives.Clinical applications of attenuated MVA poxvirus strain.From crescent to mature virion: vaccinia virus assembly and maturation.Antigen-specific vaccines for cancer treatment.Defending against smallpox: a focus on vaccines.DNA-launched live-attenuated vaccines for biodefense applications.Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.Functional insights into pathogen biology from 3D electron microscopy.Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
P2860
Q26863283-942511C3-4079-4DB0-90A4-EFFF30FDBBB8Q26995905-71B6B24F-8BEB-4E85-8A65-F501564DAC18Q27680981-417A1AA5-7BA2-4F91-A0C7-C88DBAFB5EAAQ30370948-2EDA2554-BD12-42B5-81B1-3F7D43656F4DQ33693891-091B89D2-AE58-4DCD-A65B-AC1797A4CEC4Q34024252-1179455F-4C22-42E1-9DE8-ABDC09BD50B8Q34795512-33E7EE71-9796-4332-9E46-20512E393C66Q34992708-F9871A93-964C-4792-9EBC-9699E80455A2Q35826728-B11D5BB0-B39B-45BC-BAA5-6992EF554E7CQ36399165-1F78BDD8-E046-4CB8-97F8-A3B2160D2348Q36456487-E3FDC9B9-B939-4D45-A904-47C093CF139FQ36593175-84BEBBD1-274D-412E-9710-C755C974C59CQ36846282-4F7E41D4-63D8-4A1B-9992-4651D9BDB764Q36978452-36D646E9-CEEE-4218-9C25-A4AFE3350226Q37006800-93855F1B-8186-48CB-9A89-49692263A6B7Q37255121-558F4F0C-E66B-4FDE-A73E-550265700984Q37547241-7B38A854-1CAE-4D6F-BC9F-FF66D1303584Q38009352-F345514E-2A67-47D6-A2A3-2FAE5B0EE5FFQ38156198-DBB74B13-53B5-4C80-B235-E181633C5257Q38258150-CD4269C1-5DDB-4A33-A7CC-C4093A7B185EQ38284692-76A2F750-6BC1-496D-87C7-8B4F013DAA8FQ38799357-8516BE3A-E175-45DF-98F4-42FA4BD65EFDQ40110791-017C472E-3413-4077-9E9C-91E825B22360Q40255445-CCDCC45D-F5BD-4537-A7A0-D1F25DE135EAQ41596217-739167E3-0EF9-4332-9D71-517E4478BE9CQ45325487-F34D6DBB-C3BF-4E60-8ED1-4F3A3341C2AAQ52580309-859079F5-062D-41A5-8FE3-EAE1DD1B5B00Q52688303-21979B9D-19C8-4919-AA58-4F3930CB382E
P2860
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Vaccinia viruses: vaccines aga ...... nfectious diseases and tumors.
@ast
Vaccinia viruses: vaccines aga ...... nfectious diseases and tumors.
@en
type
label
Vaccinia viruses: vaccines aga ...... nfectious diseases and tumors.
@ast
Vaccinia viruses: vaccines aga ...... nfectious diseases and tumors.
@en
prefLabel
Vaccinia viruses: vaccines aga ...... nfectious diseases and tumors.
@ast
Vaccinia viruses: vaccines aga ...... nfectious diseases and tumors.
@en
P2860
P356
P1476
Vaccinia viruses: vaccines aga ...... infectious diseases and tumors
@en
P2093
Raphael Dolin
P2860
P304
P356
10.1586/ERV.11.79
P577
2011-08-01T00:00:00Z